期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

结外NK／T细胞淋巴瘤的治疗进展 被引量：2

Treatment progress of extranodal NK/T cell lymphoma
原文传递
导出
摘要 结外NK／T细胞淋巴瘤（ENKT）是和EB病毒（EBV）感染相关的一类疾病，以鼻腔和面部中线组织进行性破坏和坏死为特征，组织学为炎性细胞背景下的弥漫性淋巴瘤细胞浸润或血管中心性和侵袭性浸润，病变进展快、侵袭性强、预后差。就结外NK／T细胞淋巴瘤的治疗进展进行探讨和总结。 Extranodal NKFF cell lymphoma is a kind of disease that is associated with EB virus infection and characterized by progressive distruction and necrosis of the nasal cavity and midline facial tissues, with histological features of diffuse lymphomatous cells infiltrate and inflammatory cells as a background or angiocentric and angioinvasive inflitrate. The prognosis is poor, as it is highly aggressive and it can progress rapidly. This article mainly discusses and reviews the progress in treatment methods.
作者 张明智（综述） 朱正峰（综述）
机构地区 郑州大学第一附属医院肿瘤五病区
出处 《白血病．淋巴瘤》 CAS 2011年第10期626-628,共3页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 T细胞 治疗 Lymphoma, T-cell Therapy
分类号 R733.4 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Isobe K, Uno T, Tamaru J, et al. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. Cancer, 2006, 106: 609-615.
  • 2Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol, 2006, 24: 181-189.
  • 3Huang M J, Jiang Y, Liu WP, et al. Early of up-front radiotherapy improved survival of localized extranndal NK/T-eeJl lymphoma, nasal type in the upper aerodigestive tract. Int J Radiation Ontology Biol Phys, 2008, 70: 166-174.
  • 4Kohrt H, Advani R. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. Leuk Lymphoma, 2009, 50: 1773-1784.
  • 5Yamaguchi M, Tobinai K, Oguchi M, et al. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/F-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol, 2009, 27: 5594-5600.
  • 6Kim S J, Kim K, Kim BS, et M. Phase II trim of eoneurrent radiation and weekly eisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to liE, nasal, extranodM NIUT-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oneol, 2009, 27: 6027-6032.
  • 7Shimada K, Suzuki R. Concurrent chemoradiotherapy for limited-stage extranodal natural killer/t-cell lymphoma, nasal type. J Clin Oncol, 2010, 28: e229; author reply e230.
  • 8Wang B, Lu JJ, Gun Y, et al. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity. Leuk Lymphoma, 2007, 48: 396-402.
  • 9林泽晓,高岩,黄慧强,林旭滨,蔡清清,夏忠军,王潇潇,姜文奇.EPOCH方案一线治疗NK/T细胞淋巴瘤的长期随访结果报告[J].中山大学学报（医学科学版）,2010,31(2):274-277. 被引量：12
  • 10Lee KW, Yun T, Kim DW, et al. First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leuk Lymphoma, 2006, 47: 1274-1282.

二级参考文献14

  • 1彭玉龙,黄慧强,林旭滨,夏忠军,李宇红,王巍,何友兼,潘战和,姜文奇,管忠震.EPOCH方案治疗外周T细胞非霍奇金淋巴瘤的临床报告[J].癌症,2004,23(8):943-946. 被引量：11
  • 2潘战和,黄慧强,林旭滨,夏云飞,夏忠军,彭玉龙,蔡清清,林桐榆,姜文奇,管忠震.鼻型NK/T细胞非霍奇金淋巴瘤预后因素探讨(附93例长期随访结果分析)[J].癌症,2005,24(12):1493-1497. 被引量：24
  • 3黄慧强,彭玉龙,黄欣,潘战和,侯景辉,吴秋良.Survivin在T细胞非霍奇金淋巴瘤组织中的表达及临床意义[J].中山大学学报（医学科学版）,2006,27(2):221-224. 被引量：7
  • 4Au WY,Weisenburger DD,Intragumtomchai T,et al.Clinical differences between nasal and extranasal natural killer/T-cell lymphoma:a study of 136 cases from the International Peripheral T-Cell Lymphoma Project[J].Blood,2009,113(17):3931-3937.
  • 5Armitage J,Vose J,Weisenburger D.International peripheral T-cell and natural killer/T-cell lymphoma study:pathology findings and clinical outcomes[J].J Clin Oncol,2008,26(25):4124-4130.
  • 6Gutierrez M,Chabner BA,Pearson D,et al.Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas:an 8-year follow-up study of EPOCH[J].J Clin Oncol,2000,18(21):3633-3642.
  • 7Koom WS,Chung EJ,Yang WI,et al.Angiocentric T-cell and NK/T-cell lymphomas:radiotherapeutic viewpoints[J].Int J Radiat Oncol Biol Phys,2004,59(4):1127-1137.
  • 8Kim WS,Song SY,Ahn YC,et al.CHOP followed by involved field radiation:is it optimal for localized nasal natural killer/T-cell lymphoma?[J].Ann Oncol,2001,12(3):349-352.
  • 9Wang B,Lu JJ,Ma X,et al.Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity[J].Leak Lymphoma,2007,48(2):396-402.
  • 10Guo Y,Lu JJ,Ma X,et al.Combined chemoradiation for the management of nasal natural killer(NK)/T-cell lymphoma:elucidating the significance of systemic chemotherapy[J].Oral Oncol,2008,44(1):23-30.

共引文献11

同被引文献23

  • 1鲁明骞,黄慧强,许新华,文彩红,王杰.EPOCH方案治疗复发耐药B细胞非霍奇金淋巴瘤的临床研究[J].肿瘤研究与临床,2006,18(3):161-162. 被引量：7
  • 2潘战和,黄慧强,蔡清清,卜庆,王步飞,廖红.96例外周T细胞非霍奇金淋巴瘤预后分析[J].中国肿瘤临床,2007,34(12):702-705. 被引量：14
  • 3Gutierrez M, Chabner BA, Pearson D, et aL Role of a doxorubiein- containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH [J]. J Clin Oncol, 2000, 18 ( 21 ) : 3633-3642.
  • 4Jaecard A, Petit B, Girault S, et al. L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and a review of the literature [J]. Ann Oneol, 2009, 20 ( 1 ) : 110-116.
  • 5Cheson BD, Homing SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group [J]. J Clin Oncol, 1999, 17(4): 1244-1253.
  • 6DevitaVTJr, HellmanS, RosenbergSA. Cancer: principle and practice of ontology [M]. 7th edition. Philadalphea: Lippincott Williams&Wilkins, 2005 : 1257.
  • 7Wilson WH, Dunleavy K, Pittaiuga, et al. Phase Ⅱ study of dose adjusted EPOCH and rituximab in un-treated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers [J]. J Clin Oncol, 2008, 26 ( 16 ) : 2717-2724.
  • 8WillsonWH, Bryant C, Bates S, etal. EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin lymphoma[J]. J Clin Oncol, 1993, 11 ( 8 ) : 1573.
  • 9Asselin BL, Whitin JC, Coppola DJ, et al. Comparative pharmaeokinetie studies of three asparaginase preparations [J]. J Clin Oneol, 1993, 11 ( 9 ) : 1780-1786.
  • 10Wang L, Wang ZH, Chen XQ, et al. First-line combination of gemeitabine, oxaliplatin, and L-asparaglnase ( GELOX ) followed by involved-field radiation therapy for patients with stage I E/ IIE extronodal natural killer / T-cell lymphoma [J]. Cancer, 2013, 119 ( 2 ) : 348-355.

引证文献2

二级引证文献3

白血病．淋巴瘤
2011年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部